Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum
- 25 January 2002
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 29 (1-2), 83-94
- https://doi.org/10.1016/s0731-7085(02)00003-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Importance of injection solution composition for LC–MS–MS methodsJournal of Pharmaceutical and Biomedical Analysis, 2001
- Novel liquid chromatographic–tandem mass spectrometric methods using silica columns and aqueous–organic mobile phases for quantitative analysis of polar ionic analytes in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- A highly automated 96‐well solid phase extraction and liquid chromatography/tandem mass spectrometry method for the determination of fentanyl in human plasmaRapid Communications in Mass Spectrometry, 2001
- High-throughput quantitative bioanalysis by LC/MS/MSBiomedical Chromatography, 2000
- Factors predictive of a beneficial response to therapy of hepatitis CHepatology, 1997
- Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppressionJournal of the American Society for Mass Spectrometry, 1996
- High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassayAntimicrobial Agents and Chemotherapy, 1989
- Quantification of ribavirin in biological fluids and tissues by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Biochemistry and clinical applications of ribavirinAntimicrobial Agents and Chemotherapy, 1986
- Evaluation of Ribavirin in the Treatment of Acute HepatitisChemotherapy, 1982